These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 10464128
1. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH. Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128 [Abstract] [Full Text] [Related]
2. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Sandborn WJ, Van O EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ. Gastroenterology; 1995 Dec; 109(6):1808-17. PubMed ID: 7498645 [Abstract] [Full Text] [Related]
3. Methotrexate for induction of remission in refractory Crohn's disease. McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598 [Abstract] [Full Text] [Related]
4. 6-thioguanine--efficacy and safety in chronic active Crohn's disease. Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF. Aliment Pharmacol Ther; 2003 Feb 15; 17(4):503-8. PubMed ID: 12622758 [Abstract] [Full Text] [Related]
5. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Cuffari C, Hunt S, Bayless T. Gut; 2001 May 15; 48(5):642-6. PubMed ID: 11302961 [Abstract] [Full Text] [Related]
6. A controlled double blind study of azathioprine in the management of Crohn's disease. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. Gut; 1995 Nov 15; 37(5):674-8. PubMed ID: 8549944 [Abstract] [Full Text] [Related]
7. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Dig Liver Dis; 2003 Sep 15; 35(9):619-27. PubMed ID: 14563183 [Abstract] [Full Text] [Related]
8. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y. J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1373-7. PubMed ID: 18662197 [Abstract] [Full Text] [Related]
9. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM. J Crohns Colitis; 2014 Feb 15; 8(2):120-8. PubMed ID: 23932783 [Abstract] [Full Text] [Related]
10. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Prefontaine E, Macdonald JK, Sutherland LR. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270 [Abstract] [Full Text] [Related]
11. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M, AZTEC Study Group. Gastroenterology; 2013 Oct 07; 145(4):766-74.e1. PubMed ID: 23770132 [Abstract] [Full Text] [Related]
12. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P. Inflamm Bowel Dis; 2009 Mar 07; 15(3):375-82. PubMed ID: 19009634 [Abstract] [Full Text] [Related]
13. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients. Liu Q, Wang Y, Mei Q, Han W, Hu J, Hu N. Scand J Gastroenterol; 2016 Sep 07; 51(9):1093-9. PubMed ID: 27152547 [Abstract] [Full Text] [Related]
14. Intravenous azathioprine in severe ulcerative colitis: a pilot study. Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ. Am J Gastroenterol; 2000 Dec 07; 95(12):3463-8. PubMed ID: 11151878 [Abstract] [Full Text] [Related]
15. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases]. Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A. Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579 [Abstract] [Full Text] [Related]
16. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M. Ther Drug Monit; 2007 Feb 04; 29(1):1-5. PubMed ID: 17304143 [Abstract] [Full Text] [Related]
17. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR, ISIS 2302-CS9 Investigators. Gut; 2002 Jul 04; 51(1):30-6. PubMed ID: 12077088 [Abstract] [Full Text] [Related]
18. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208 [Abstract] [Full Text] [Related]
19. Azathioprine: state of the art in inflammatory bowel disease. Sandborn WJ. Scand J Gastroenterol Suppl; 1998 Jun 01; 225():92-9. PubMed ID: 9515759 [Abstract] [Full Text] [Related]
20. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA, McDonald JW, Feagan BG. Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908 [Abstract] [Full Text] [Related] Page: [Next] [New Search]